Tag: weight loss
Oral GLP-1 medication shows major promise for type 2 diabetes: weight loss and blood sugar control in pivotal trial
A pivotal clinical trial demonstrates that a new oral GLP-1 medication achieves substantial improvements in blood sugar control and weight…
GLP-1 Weight Loss Drugs Linked to Reduced Physical Activity Despite Weight Loss Success
New research analyzing Fitbit data reveals that people taking GLP-1 weight loss drugs experience declining physical activity levels despite successful…
FDA Updates Alli Weight Loss Drug Label with Kidney Injury Warning
FDA mandates new kidney injury warnings on alli weight loss drug labels. The updated labeling requires consumers to consult healthcare…
Survodutide Weekly Injection Shows 17.5% Weight Loss in Phase 3 Obesity Trial
Phase 3 trial shows survodutide weekly injection achieved 17.5% weight loss versus 1.2% placebo in over 3,400 adults with obesity.…
Oral GLP-1 Drug Achieves 11.3% Weight Loss in Phase 2 Trial
Phase 2b trial shows oral GLP-1 drug aleniglipron achieved 11.3% weight loss in 230 adults with obesity. Results suggest oral…
Intermittent Fasting Rewires Brain and Gut Microbiome, New Study Reveals
New research reveals intermittent fasting triggers coordinated changes in brain appetite control regions and gut microbiome composition. The findings suggest…
Weight Loss Expert Raises Safety Concerns Over Unregulated GLP-1 ‘Microdoses’
Weight-loss specialist warns about unregulated GLP-1 microdosing trend lacking clinical trial evidence. Long-term safety effects remain unknown for reduced-dose formulations.
Scientists Discover Why Ozempic and Wegovy Weight Loss Plateaus After Initial Success
NIH scientists have discovered why GLP-1 weight-loss medications like Ozempic and Wegovy eventually plateau, with 47% of patients experiencing reduced…